Further progress in understanding the pathophysiology of primary dystonia

Movement Disorders

Volumn 26, Issue 7, 2011, Pages 1185-1186

  Abbruzzese, Giovanni ^a   Berardelli, Alfredo ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

CENTRAL NERVOUS SYSTEM; DYSTONIA; EDITORIAL; HUMAN; MOTOR DYSFUNCTION; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORIMOTOR INTEGRATION;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DYSTONIC DISORDERS; FEMALE; HUMANS; MALE; NEURONAL PLASTICITY; TORTICOLLIS;

EID: 79959344843     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23707     Document Type: Editorial

References (16)

1. Abbruzzese G, Berardelli A. Sensorimotor integration in movement disorders. Mov Disord 2003; 18: 231-240.
2. Quartarone A, Morgante F, Sant'angelo A, et al. Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia. J Neurol Neurosurg Psychiatry 2008; 79: 985-990.
3. Ziemann U, Paulus W, Nitsche MA, et al. Consensus: motor cortex plasticity protocols. Brain Stimul 2008; 1: 164-182.
4. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007; 130: 1183-1193.
5. Kojovic M, Caronni A, Bologna M, Rothwell JC, Bhatia KP, Edwards MJ. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov Disord 2011, in press.
6. Abbruzzese G, Berardelli A. Neurophysiological effects of botulinum toxin type A. Neurotox Res 2006; 9: 109-114.
7. Currà A, Trompetto C, Abbruzzese G, Berardelli A. Central effects of botulinum toxin type A: evidence and supposition. Mov Disord 2004; 19(Suppl 8): S60-S64.
8. Currà A, Berardelli A. Do the unintended actions of botulinum toxin at distant sites have clinical implications? Neurology 2009; 72: 1095-1099.
9. Gilio F, Currà A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 2000; 48: 20-26.
10. Byrnes ML, Thickbroom GW, Wilson SA, et al. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection. Brain 1998; 121: 977-988.
11. Murase N, Rothwell JC, Kaji R, et al. Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain 2005; 128: 104-115.
12. Koch G, Schneider S, Bäumer T, et al. Altered dorsal premotor-motor interhemispheric pathway activity in focal arm dystonia. Mov Disord 2008; 23: 660-668.
13. Seung-Hyun J, Lin P, Sungyoung A, Hallett M. Abnormal functional connectivity in focal hand dystonia: mutual information analysis in EEG. Mov Disord 2011, in press.
14. Kristeva R, Chakarov V, Losch F, Hummel S, Popa T, Schulte-Mönting J. Electroencephalographic spectral power in writer's cramp patients: evidence for motor cortex malfunctioning during the cramp. Neuroimage 2005; 27: 706-714.
15. Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009; 29: 9740-9747.
16. Pelosin E, Bove M, Marinelli L, Abbruzzese G, Ghilardi MF. Cervical dystonia affects aimed movements of nondystonic segments. Mov Disord 2009; 24: 1955-1961.